NURS617/ NURS 617
Pharmacotherapeutics Review Exam 1
Actual Exam 2026/2027 – Complete
Exam-Style Questions with Detailed
Rationales | 100% Verified – Pass
Guaranteed – A+ Graded
, 1. A patient with severe hypoalbuminemia is prescribed warfarin, a
highly protein-bound drug. Which pharmacokinetic change should
the Nurse Practitioner anticipate? A) Decreased therapeutic effect due
to rapid excretion B) Increased fraction of free drug, increasing the risk
of toxicity C) Decreased volume of distribution D) Increased first-pass
metabolism in the liver
2. Which of the following best describes the 'First-Pass Effect'? A)
The initial distribution of a drug to highly perfused organs like the brain
B) The rapid renal excretion of a drug immediately following
intravenous administration C) The extensive metabolism of an oral drug
in the liver before it reaches systemic circulation D) The binding of a
drug to plasma proteins during its first circuit through the heart
3. A patient is taking a drug that is a known CYP450 enzyme
inducer. If they are started on a second drug metabolized by the
same pathway, the NP should expect the second drug's serum levels
to: A) Increase, potentially leading to toxicity B) Decrease, potentially
leading to subtherapeutic levels C) Remain unchanged as induction only
affects the inducer D) Increase initially, then decrease rapidly after 24
hours
4. A drug has a half-life of 6 hours. If a patient takes a single dose,
approximately how long will it take for the drug to be 94%
eliminated from the body? A) 6 hours B) 12 hours C) 24 hours D) 48
hours
5. Which parameter is used to determine the safety of a drug by
comparing the dose that produces a toxic effect to the dose that
produces a therapeutic effect? A) Efficacy B) Potency C) Therapeutic
Index D) Bioavailability
Pharmacotherapeutics Review Exam 1
Actual Exam 2026/2027 – Complete
Exam-Style Questions with Detailed
Rationales | 100% Verified – Pass
Guaranteed – A+ Graded
, 1. A patient with severe hypoalbuminemia is prescribed warfarin, a
highly protein-bound drug. Which pharmacokinetic change should
the Nurse Practitioner anticipate? A) Decreased therapeutic effect due
to rapid excretion B) Increased fraction of free drug, increasing the risk
of toxicity C) Decreased volume of distribution D) Increased first-pass
metabolism in the liver
2. Which of the following best describes the 'First-Pass Effect'? A)
The initial distribution of a drug to highly perfused organs like the brain
B) The rapid renal excretion of a drug immediately following
intravenous administration C) The extensive metabolism of an oral drug
in the liver before it reaches systemic circulation D) The binding of a
drug to plasma proteins during its first circuit through the heart
3. A patient is taking a drug that is a known CYP450 enzyme
inducer. If they are started on a second drug metabolized by the
same pathway, the NP should expect the second drug's serum levels
to: A) Increase, potentially leading to toxicity B) Decrease, potentially
leading to subtherapeutic levels C) Remain unchanged as induction only
affects the inducer D) Increase initially, then decrease rapidly after 24
hours
4. A drug has a half-life of 6 hours. If a patient takes a single dose,
approximately how long will it take for the drug to be 94%
eliminated from the body? A) 6 hours B) 12 hours C) 24 hours D) 48
hours
5. Which parameter is used to determine the safety of a drug by
comparing the dose that produces a toxic effect to the dose that
produces a therapeutic effect? A) Efficacy B) Potency C) Therapeutic
Index D) Bioavailability
